首页|期刊导航|西南医科大学学报|4-辛基衣康酸对压力超负荷所致心力衰竭的作用及机制

4-辛基衣康酸对压力超负荷所致心力衰竭的作用及机制OA

Effect and Mechanism of 4-Octyl Itaconate on Pressure Overload-Induced Heart Failure

中文摘要英文摘要

目的 探讨4-辛基衣康酸(4-octyl itaconate,4-OI)对压力超负荷所致心力衰竭的作用及其可能机制.方法 将30只8周龄的无特定病原体(SPF)级雄性C57BL/6J小鼠随机分为假手术组(Sham,n=6)、4-辛基衣康酸组(Sham+4-OI,n=8)、模型组(TAC,n=8)、模型+4-辛基衣康酸组(TAC+4-OI,n=8).TAC组和TAC+4-OI组采用胸主动脉缩窄术(transverse aortic constriction,TAC)构建压力超负荷介导的心力衰竭模型.Sham+4-OI组和TAC+4-OI组术后每周2次腹腔注射50 mg/kg的4-OI溶液,Sham组和TAC组同时腹腔注射等体积、同配方但不含4-OI的空白溶剂,持续8周.超声心动图评估心功能,测量心脏相关参数(n=6).苏木精-伊红染色(hematoxylin-eosin,HE)观察各组小鼠的心脏形态改变和炎症浸润情况,天狼星红染色评估各组小鼠的心脏胶原沉积.免疫印迹法(Western blot,n=3)和实时荧光定量逆转录聚合酶链反应(qRT-PCR,n=6)检测小鼠心肌组织纤维化标志物COL3A1、SERPINE1的蛋白和mRNA水平,并运用RNA测序(RNA-seq,n=6)探索4-OI改善压力超负荷所致心力衰竭的潜在机制.统计学方法采用单因素方差分析和Tukey检验.结果 与Sham组相比,TAC组小鼠心室重构(LVIDd,IVSd,LVPWd)加重、心脏功能(LVEF,LVFS)下降(均P<0.05),心肌纤维化标志物COL3A1和SERPINE1的蛋白(P<0.05)和mRNA(P<0.001)水平升高.而与TAC组相比,TAC+4-OI组小鼠心室重构(LVIDd,IVSd,LVPWd)减轻、心脏功能(LVEF,LVFS)改善(均P<0.05),心肌纤维化标志物COL3A1和SERPINE1的蛋白(P<0.05)及mRNA(P<0.001)表达水平下降.这些结果提示4-OI对压力超负荷所致心力衰竭具有改善作用.通过对各组小鼠心肌组织行RNA-seq寻找差异基因,并进行PPI网络、GO和KEGG富集分析,发现4-OI干预调控了MMP9、VWF、LCN2、CD163、LTF等基因的表达,差异基因的功能和相关通路富集分析显示,这些差异基因与免疫调节相关性较强.结论 4-OI可改善压力超负荷所致心力衰竭,其机制可能与调控免疫相关核心基因表达有关.

Objective To investigate the effects of 4-octyl itaconate(4-OI)on pressure-induced heart failure and its potential mechanisms.Methods Thirty 8-week-old male SPF C57BL/6J mice were randomly divided into a sham surgery group(Sham group,n=6),a 4-octyl itaconate group(Sham+4-OI group,n=8),the model group(TAC group,n=8),and the model+4-octyl itaconate group(TAC+4-OI group,n=8).The TAC and TAC+4-OI groups were subjected to transverse aortic constriction(TAC)to establish a model of pressure overload-mediated heart failure.The Sham+4-OI group and the TAC+4-OI group received intraperitoneal injections of a 50 mg/kg 4-OI solution twice a week post-surgery,while the Sham group and the TAC group received intraperitoneal injections of an equal volume,identically formulated blank solvent(without 4-OI)at the same time,for 8 weeks.Cardiac function was assessed by echocardiography,and cardiac parameters were measured(n=6).Hematoxylin-eosin(HE)staining was used to observe cardiac mor-phological changes and inflammatory infiltration in mice from each group,while Sirius red staining was used to assess cardiac collagen deposition.Western blot(n=3)and real-time quantitative reverse transcription polymerase chain reaction(qRT-PCR,n=6)were used to detect the levels of the myocardial fibrosis markers COL3A1 and SERPINE1 in mouse myocardial tissue,and RNA sequencing(RNA-seq,n=6)was employed to explore the potential mechanisms by which 4-OI ameliorates heart failure induced by pressure over-load.Statistical analysis was performed using one-way analysis of variance(ANOVA)and Tukey's test.Results Compared with the Sham group,mice in the TAC group exhibited worsened ventricular remodeling(LVIDd,IVSd,LVPWd)and reduced cardiac func-tion(LVEF,LVFS)(all P<0.05),as well as elevated protein(P<0.05)and mRNA(P<0.001)levels of the myocardial fibrosis mark-ers COL3A1 and SERPINE1.In contrast to the TAC group,mice in the TAC+4-OI group exhibited reduced ventricular remodeling(LVIDd,IVSd,LVPWd)and improved cardiac function(LVEF,LVFS)(all P<0.05),along with decreased protein(P<0.05)and mRNA(P<0.001)expression levels of the myocardial fibrosis markers COL3A1 and SERPINE1.These results suggest that 4-OI exerts a beneficial effect on pressure overload-induced heart failure.By performing RNA-seq on myocardial tissue from mice in each group to identify differentially expressed genes and conducting PPI,GO,and KEGG enrichment analyses,we found that 4-OI intervention regulated the expression of genes such as MMP9,VWF,LCN2,CD163,and LTF.Functional and pathway enrichment analyses of the dif-ferentially expressed genes revealed a strong association with immune-related processes.Conclusion 4-OI improves pressure overload-induced heart failure,and its mechanism may be related to the regulation of the expression of core immune-related genes.

李特;刘婷婷;庞金伟;范忠才;杨萍

西南医科大学附属医院 心血管内科(泸州 646000)西南医科大学附属医院 心血管内科(泸州 646000)西南医科大学附属医院 心血管内科(泸州 646000)西南医科大学附属医院 心血管内科(泸州 646000)西南医科大学附属医院 心血管内科(泸州 646000)

医药卫生

4-辛基衣康酸心力衰竭主动脉缩窄压力超负荷免疫调节

4-octyl itaconateHeart failureTransverse aortic constrictionPressure overloadImmunoregulation

《西南医科大学学报》 2026 (5)

616-622,7

四川省科技厅重大科技专项(2025YFRG0005)

10.3969/j.issn.2096-3351.2026.05.008

评论